prof. RNDr. Lenka Zdražilová Dubská, Ph.D.
Head of the research group, Lenka Zdražilová Dubská Research Group: Innovative ATMP for rare diseases
Correspondence Address:
Palachovo nám. 726/3, 625 00 Brno
Office: bldg. C03/333
Kamenice 753/5
625 00 Brno
Phone: | +420 549 49 8238 |
---|---|
E‑mail: |
social and academic networks: |
---|
Total number of publications: 110
2021
-
CoVigi phase IV multicentric trial evaluating COVID-19 vaccination adverse events and immune response dynamics in cancer patients: First results on antibody and cellular immunity
Year: 2021, type: Conference abstract
-
Drug interaction profile of TKI alectinib allows effective and safe treatment of ALK plus lung cancer in the kidney transplant recipient
International Immunopharmacology, year: 2021, volume: 99, edition: October 2021, DOI
-
Efektivita časné léčby COVID-19 kombinující remdesivir a rekonvalescentní plazmu s vysokým titrem u hematologických pacientů.
Year: 2021, type: Conference abstract
-
Interpretive discrepancies caused by target values inter-batch variations in chemiluminescence immunoassay for SARS-CoV-2 IgM/IgG by MAGLUMI
Journal of Medical Virology, year: 2021, volume: 93, edition: 3, DOI
-
PET/CT-tailored treatment of locally advanced oesophago-gastric junction adenocarcinoma: a report on the feasibility of the multicenter GastroPET study
THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY, year: 2021, volume: 13, edition: December 2021, DOI
-
Strict Adherence to Anti-Epidemic Measures PreventsICU Staff from SARS-Cov2 Infection
Biomedical and Pharmacology Journal, year: 2021, volume: 14, edition: 4, DOI
-
Successful early treatment combining remdesivir with high-titer convalescent plasma among COVID-19-infected hematological patients
Hematological Oncology, year: 2021, volume: 39, edition: 5, DOI
2020
-
Comprehensive Molecular Profiling for Relapsed/Refractory Pediatric Burkitt Lymphomas-Retrospective Analysis of Three Real-Life Clinical Cases-Addressing Issues on Randomization and Customization at the Bedside
Frontiers in Oncology, year: 2020, volume: 9, edition: FEB 2020, DOI
-
Editorial: Precision/Personalized Pediatric Oncology and Immune Therapies: Rather Customize Than Randomize
Year: 2020, type: Article in Periodical (without peer review)
-
Naléhavé nálezy v hematologické laboratorní a klinické diagnostice aneb kdy je nutno zpozornět a zejména upozornit.
Year: 2020